Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis

Advances in pharmacotherapy for allergic conjunctivitis

(2015) Mark B Abelson et al.   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy of Olopatadine versus Epinastine for Treating Allergic Conjunctivitis Caused by Japanese Cedar Pollen: A Double-Blind Randomized Controlled Trial

(2014) Atsuki Fukushima et al.   ADVANCES IN THERAPY

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

(2014) Eugene B. McLaurin et al.   ADVANCES IN THERAPY

Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge

(2014) Hiroshi Fujishima et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Topical Cyclosporine in the Treatment of Allergic Conjunctivitis

(2013) Kelvin Ho-Nam Wan et al.   OPHTHALMOLOGY

A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis

(2009) Lanny J. Rosenwasser et al.   ALLERGY AND ASTHMA PROCEEDINGS

Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial

(2008) Mehmet Borazan et al.   ACTA OPHTHALMOLOGICA